Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: Its diagnostic value for endometrial carcinoma

Communications in Clinical Cytometry

Volumn 30, Issue 1, 1997, Pages 23-27

  Kobayashi, Yoichi ^a   Tsukazaki, Katsumi ^b   Ohta, Kunihiko ^b   Mikami, Mikio ^b   Kubushiro, Kaneyuki ^b   Nozawa, Shiro ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

cancer; diagnosis; endometrium; flow cytometry; glycolipid; monoclonal antibody

Indexed keywords

GLYCOLIPID; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 0030953169     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19970215)30:1<23::AID-CYTO3>3.0.CO;2-G     Document Type: Article

References (15)

1. Geisinger KR, Kute TE, Marshall RB, Homesley HD, Morgan TM: Analysis of the relationships on the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of the endometrium. Am J Clin Pathol 85:536-541, 1986.
2. Ikeda M, Watanabe Y, Nanjoh T, Noda K: Evaluation of DNA ploidy in endometrial cancer. Gynecol Oncol 50:25-29, 1993
3. Iversen OE: Flowcytometric deoxyribonucleic acid index. A prognostic factor in endometrial carcinoma. Am J Obstet Gynecol 155:770-776, 1986.
4. b. J Biochem 105:718-722, 1989.
5. Koss LG, Scheriber K, Moussouris H, Oberlander S: Endometrial carcinoma and its precursors: Detection and screening. Clin Obstet Gynecol 25:49-61, 1982.
6. Newbury R, Schuerch C, Goodspeed N, Fanning J, Glidewell O, Evans M: DNA content as a prognostic factor in endometrial carcinoma. Obstet Gynecol 76:251-257, 1990.
7. Nozawa S, Sakayori M, Ohta K, Iizuka K, Mochizuki H, Soma M, Fujimoto J, Hata J, Iwamori M, Nagai Y: A monoclonal antibody (MSN-1) against a newly established cell line (SNG-II) and its application to immunohistochemistry and How cytometry. Am J Obstet Gynecol 161:1079-1086, 1989.
8. Parazzini F, Vecchia CL, Bocciolone L, Franceschi S: The epidemiology of endometrial cancer. Gynecol Oncol 41:1-16, 1991.
9. Reagan J: Can screening of endometrial cancer be justified? Acta Cytol 24:87-89, 1980.
10. Schwartz AM, Silverberg SG, Fu YS, Nozawa S, Huang S, Tsukazaki K, Williams KR: Use of monoclonal antibodies MSN-1 and B72.3 in the prediction of the natural history of endometrial hyperplasia. Int J Gynecol Pathol 12:253-258, 1993.
11. Susini T, Rapi S, Savino L, Boddi V, Berti P, Massi G: Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: Comparison with other clinical-pathologic parameters. Am J Obstet Gynecol 170:527-534, 1994.
12. Susumu N, Kawakami H, Aoki D, Hirano H, Nozawa S: Subcellular localization of blood group Leb carbohydrate antigen (MSN-1 reactive-antigen) in endometrial cancer cells. Cancer Res 53:3643-3648, 1993.
13. Ueda M, Ueki M, Kumagai K, Ueki K, Ikeda A, Morikawa M: Clinical evaluation of the Endosearch sampler in endometrial cytology - a preliminary report. J Medicine 25:305-318, 1994.
14. Van Dam PA, Lowe DG, Watson JV, James M, Chard T, Hudson CN, Shepherd JH: Multiparameter llow-cytometric quantitalion of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract. Gynecol Oncol 1991:256-264, 1991.
15. Yabushita H, Masuda T, Sawaguchi K, Noguchi M, Nakanishi M: Growth potential of endometrial cancers assessed by a Ki-67 Ag/DNA dual-color flow-cytometric assay. Gynecol Oncol 44:263-267, 1992.